Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Specialty Generics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Specialty Generics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Specialty Generics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Specialty Generics products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Specialty Generics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Specialty Generics market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Specialty Generics development has been the leading industry trend of Specialty Generics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Specialty Generics Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Injectables, Oral, Others |
| By Application Outlook |
Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Teva Pharmaceuticals USA, Inc., Mylan N.V., Sandoz International GmbH, Akorn, Inc., Mallinckrodt, Valeant Pharmaceuticals International, Inc., Pfizer Inc., Endo Pharmaceuticals Inc., Apotex Corp., Sun Pharmaceutical Industries Ltd. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Teva Pharmaceuticals USA
- Inc.
- Mylan N.V.
- Sandoz International GmbH
- Akorn
- Inc.
- Mallinckrodt
- Valeant Pharmaceuticals International
- Inc.
- Pfizer Inc.
- Endo Pharmaceuticals Inc.
- Apotex Corp.
- Sun Pharmaceutical Industries Ltd.
SPECIALTY GENERICS Market, By Type
SPECIALTY GENERICSMarket, By Application
- Oncology
- Inflammatory Conditions
- Multiple Sclerosis
- Hepatitis C
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Specialty Generics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Specialty Generics
1.1 Specialty Generics Market Overview
1.1.1 Specialty Generics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Specialty Generics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Specialty Generics Market by Type
1.3.1 Injectables
1.3.2 Oral
1.3.3 Others
1.4 Specialty Generics Market by End Users/Application
1.4.1 Oncology
1.4.2 Inflammatory Conditions
1.4.3 Multiple Sclerosis
1.4.4 Hepatitis C
2 Global Specialty Generics Competition Analysis by Players
2.1 Specialty Generics Market Size (Value) by Players (2017 and 2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Teva Pharmaceuticals USA, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Specialty Generics Revenue (Value) (2013-2018)
3.1.5 Recent Developments
3.2 Mylan N.V.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Specialty Generics Revenue (Value) (2013-2018)
3.2.5 Recent Developments
3.3 Sandoz International GmbH
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Specialty Generics Revenue (Value) (2013-2018)
3.3.5 Recent Developments
3.4 Akorn, Inc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Specialty Generics Revenue (Value) (2013-2018)
3.4.5 Recent Developments
3.5 Mallinckrodt
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Specialty Generics Revenue (Value) (2013-2018)
3.5.5 Recent Developments
3.6 Valeant Pharmaceuticals International, Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Specialty Generics Revenue (Value) (2013-2018)
3.6.5 Recent Developments
3.7 Pfizer Inc.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Specialty Generics Revenue (Value) (2013-2018)
3.7.5 Recent Developments
3.8 Endo Pharmaceuticals Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Specialty Generics Revenue (Value) (2013-2018)
3.8.5 Recent Developments
3.9 Apotex Corp.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Specialty Generics Revenue (Value) (2013-2018)
3.9.5 Recent Developments
3.10 Sun Pharmaceutical Industries Ltd.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Specialty Generics Revenue (Value) (2013-2018)
3.10.5 Recent Developments
4 Global Specialty Generics Market Size by Type and Application (2013-2018)
4.1 Global Specialty Generics Market Size by Type (2013-2018)
4.2 Global Specialty Generics Market Size by Application (2013-2018)
4.3 Potential Application of Specialty Generics in Future
4.4 Top Consumer/End Users of Specialty Generics
5 North America Specialty Generics Development Status and Outlook
5.1 North America Specialty Generics Market Size (2013-2018)
5.2 North America Specialty Generics Market Size and Market Share by Players (2017 and 2018)
6 Europe Specialty Generics Development Status and Outlook
6.1 Europe Specialty Generics Market Size (2013-2018)
6.2 Europe Specialty Generics Market Size and Market Share by Players (2017 and 2018)
7 China Specialty Generics Development Status and Outlook
7.1 China Specialty Generics Market Size (2013-2018)
7.2 China Specialty Generics Market Size and Market Share by Players (2017 and 2018)
8 Rest of Asia Pacific Specialty Generics Development Status and Outlook
8.1 Rest of Asia Pacific Specialty Generics Market Size (2013-2018)
8.2 Rest of Asia Pacific Specialty Generics Market Size and Market Share by Players (2017 and 2018)
9 Central & South America Specialty Generics Development Status and Outlook
9.1 Central & South America Specialty Generics Market Size (2013-2018)
9.2 Central & South America Specialty Generics Market Size and Market Share by Players (2017 and 2018)
10 Middle East & Africa Specialty Generics Development Status and Outlook
10.1 Middle East & Africa Specialty Generics Market Size (2013-2018)
10.2 Middle East & Africa Specialty Generics Market Size and Market Share by Players (2017 and 2018)
11 Market Forecast by Regions, Type and Application (2018-2025)
11.1 Global Specialty Generics Market Size (Value) by Regions (2018-2025)
11.1.1 North America Specialty Generics Revenue and Growth Rate (2018-2025)
11.1.2 Europe Specialty Generics Revenue and Growth Rate (2018-2025)
11.1.3 China Specialty Generics Revenue and Growth Rate (2018-2025)
11.1.4 Rest of Asia Pacific Specialty Generics Revenue and Growth Rate (2018-2025)
11.1.5 Central & South America Specialty Generics Revenue and Growth Rate (2018-2025)
11.1.6 Middle East & Africa Specialty Generics Revenue and Growth Rate (2018-2025)
11.2 Global Specialty Generics Market Size (Value) by Type (2018-2025)
11.3 Global Specialty Generics Market Size by Application (2018-2025)
12 Specialty Generics Market Dynamics
12.1 Specialty Generics Market Opportunities
12.2 Specialty Generics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Specialty Generics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Specialty Generics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
